Photodynamic Therapy in Practice: A Review of Experiences with Myopic CNV in Korean Patients.
- Author:
Eun Jee CHUNG
1
;
Hyun Sub OH
;
Hyoung Jun KOH
;
Sung Chul LEE
;
Oh Woong KWON
Author Information
1. The Institute of Vision Research Department of Ophthalmology, College of Medicine, Yonsei University, Seoul, Korea. owkwon0301@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Choroidal neovascularization (CNV);
Pathologic myopia;
Photodynamic therapy (PDT)
- MeSH:
Choroidal Neovascularization;
Fluorescein Angiography;
Follow-Up Studies;
Humans;
Myopia;
Photochemotherapy*;
Retrospective Studies;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2005;46(4):664-670
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the effects of photodynamic therapy with verteporfin on visual acuity and fluorescein angiography in choroidal neovascularization (CNV) associated with pathologic myopia and to determine if this treatment could reproduce the results achieved in the Verteporfin in Photodynamic Therapy (VIP) Trial in Korean patients. METHODS: Forty-two eyes of 39 patients with CNV secondary to pathologic myopia were included. A retrospective review of their clinical records and fluorescein angiography was done. The patients underwent photodynamic therapy with verteporfin and were followed up for more than 6 months after the therapy. The change in best corrected visual acuity (BCVA) and leakage in fluorescein angiography were evaluated. RESULTS: The mean age of the patients was 39.6 and mean follow-up period was 23.5 months. The BCVA of the patients improved in 22 (52.4%) eyes, was unchanged in 13 (30.9%), and worsened in 7 (16.7%). The leakage in fluorescein angiography decreased in 25 (59.5%) eyes. CONCLUSIONS: Photodynamic therapy with verteporfin for myopic CNV in Korean patients appeared to be effective in stabilization of the lesions and improvement of visual acuity.
